Share This Page
Drug Price Trends for NDC 16729-0292
✉ Email this page to a colleague
Average Pharmacy Cost for 16729-0292
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DALFAMPRIDINE ER 10 MG TABLET | 16729-0292-12 | 0.51378 | EACH | 2025-03-19 |
| DALFAMPRIDINE ER 10 MG TABLET | 16729-0292-12 | 0.46956 | EACH | 2025-02-19 |
| DALFAMPRIDINE ER 10 MG TABLET | 16729-0292-12 | 0.46628 | EACH | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 16729-0292
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for Pharmaceutical Products: A Comprehensive Guide
Understanding the National Drug Code (NDC)
To analyze and project prices for pharmaceutical products, it is crucial to understand the National Drug Code (NDC) system. The NDC is a unique, three-segment number that serves as the FDA’s identifier for drugs. It includes the labeler code, product code, and package code, providing detailed information about the drug product, its manufacturer, and packaging[1][5].
The Role of NDC in Market Analysis
The NDC Directory, maintained by the FDA, contains information on active and certified finished and unfinished drugs. This directory is essential for market analysis as it provides a comprehensive list of drugs, including their pricing and utilization data. For example, the NDC Directory helps in tracking the market presence of specific drugs, their pricing trends, and the impact of new drug approvals and patent expirations on the market[1][5].
Current Market Trends in Pharmaceutical Spending
Pharmaceutical expenditures have been on the rise, driven by factors such as increased utilization, new drug approvals, and price increases. In 2023, overall pharmaceutical expenditures in the US grew by 13.6% compared to 2022, reaching a total of $722.5 billion. This growth was largely driven by increased utilization, new drugs, and price increases[4].
Utilization and New Drugs
Utilization has been a significant driver of pharmaceutical spending. For instance, in clinics, increased utilization drove a 15.0% increase in drug expenditures. New drugs, particularly in categories like specialty, endocrine, and cancer treatments, are expected to continue driving expenditures in 2024[4].
Price Increases
Price increases have also played a critical role in the rising expenditures. While the number of drugs with significant price increases has declined, the magnitude of these increases has risen. For example, generic drugs that exceeded the 15% annual price increase threshold saw an average increase of 176.7% in 2019, indicating sharper price hikes for lower-priced generics[2].
Impact of Technological Advancements
Technological advancements, such as AI and gene editing, are transforming the pharmaceutical industry. AI is accelerating drug development by analyzing vast datasets and predicting drug success rates with high accuracy. This not only reduces the time and cost of bringing new drugs to market but also enhances the efficiency of the development process[3].
AI in Drug Development
AI is becoming an essential partner in research labs, allowing scientists to explore more options in a shorter time. This trend is expected to continue in 2025, with AI playing a pivotal role in drug discovery and development. The integration of AI with sustainable practices and regulatory compliance will be crucial for companies to maximize their market positioning and innovation capabilities[3].
Regulatory and Policy Impacts
Regulatory changes and policy shifts can significantly impact pharmaceutical pricing and market dynamics. For instance, transparency in drug pricing, as seen in reports on prescription drug cost transparency, can influence how manufacturers set their prices. Policies aimed at controlling price increases, such as those affecting wholesale acquisition costs (WAC), can also shape the market landscape[2].
Price Projections for 2024
For 2024, overall prescription drug spending is expected to rise by 10.0% to 12.0%. In clinics and hospitals, the increase is anticipated to be between 11.0% to 13.0% and 0% to 2.0%, respectively, compared to 2023. These projections are influenced by factors such as new drug approvals, patent expirations, and potential new policies or legislation[4].
Specific Drug Price Projections
To project prices for a specific NDC, such as 16729-0292, one would need to consider the broader market trends, the drug's category (e.g., generic, brand, specialty), and any recent changes in its pricing or utilization. Here are some steps to follow:
- Category Analysis: Determine the category of the drug (e.g., generic, brand) and its therapeutic class. This helps in understanding the competitive landscape and pricing dynamics.
- Utilization Trends: Analyze historical utilization data to predict future demand. Increased utilization can drive up prices.
- Price History: Review the drug's price history, including any significant increases or decreases. This can help in identifying patterns and potential future changes.
- Regulatory and Policy Changes: Consider any regulatory or policy changes that might impact the drug's pricing. For example, transparency laws or price control measures.
- Technological and Market Innovations: Assess how technological advancements and market innovations might affect the drug's pricing and market position.
Case Study: NDC 16729-0292
Without specific data on the drug associated with NDC 16729-0292, we can still apply the general principles outlined above.
- Category: If the drug is a generic, it might be subject to sharper price increases compared to brand drugs, as seen in recent trends[2].
- Utilization: If the drug has seen increased utilization, this could drive up its price in 2024.
- Price History: Reviewing the drug's past price changes can help predict future trends.
- Regulatory and Policy Changes: Any changes in transparency laws or price control policies could impact the drug's pricing.
Example Projection
Assuming the drug is a generic with increasing utilization and no significant regulatory changes, a moderate price increase of 10% to 15% could be projected for 2024, aligning with broader market trends.
Key Takeaways
- NDC Importance: The National Drug Code is crucial for identifying and tracking pharmaceutical products in the market.
- Market Trends: Pharmaceutical spending is driven by utilization, new drug approvals, and price increases.
- Technological Impact: AI and other technological advancements are transforming drug development and market dynamics.
- Regulatory Impact: Policy changes and regulatory shifts can significantly affect drug pricing.
- Price Projections: Specific drug price projections require analysis of category, utilization trends, price history, and regulatory changes.
FAQs
What is the National Drug Code (NDC)?
The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs, including the labeler code, product code, and package code.
How do technological advancements impact drug development?
Technological advancements, such as AI and gene editing, accelerate drug development by analyzing vast datasets, predicting drug success rates, and enhancing the efficiency of the development process.
What factors influence pharmaceutical spending?
Pharmaceutical spending is influenced by increased utilization, new drug approvals, price increases, and regulatory or policy changes.
How can I project prices for a specific drug NDC?
To project prices, analyze the drug's category, utilization trends, price history, and any regulatory or policy changes that might impact its pricing.
What are the expected changes in pharmaceutical spending for 2024?
Overall prescription drug spending is expected to rise by 10.0% to 12.0% in 2024, with varying increases in different sectors such as clinics and hospitals.
Sources
- FDA's National Drug Code Directory: Contains information about finished drug products, unfinished drugs, and compounded drug products[1].
- Attorney General's Report on Prescription Drug Cost Transparency: Provides insights into drug price trends and transparency[2].
- The Future of Pharma: 2025's Key Trends To Know: Discusses the impact of technological advancements on the pharmaceutical industry[3].
- National trends in prescription drug expenditures and projections for 2024: Reports historical patterns and predicts future spending in the pharmaceutical sector[4].
- National Drug Code Database Background Information - FDA: Explains the structure and significance of the NDC Directory[5].
More… ↓
